Funding for this research was provided by:
Vascular Graft Solutions Ltd
Received: 28 June 2018
Accepted: 5 November 2018
First Online: 19 November 2018
Ethics approval and consent to participate
: The study protocol conformed to the Declaration of Helsinki and was approved by a UK Research Ethics Committee (NRES Committee London – City Road & Hampstead, REC reference 15/LO/1862). Each patient gave their informed consent to participate in the study.
: Not applicable.
: Prof Taggart serves as a consultant to Vascular Graft Solutions, has stock ownership and receives consulting fees. Prof Taggart has received travel support and speaking honoraria from Vascular Graft Solutions. The remaining authors have no disclosures relating to this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.